Treanda 45 mg/0.5 mL single-dose vial Images
Generic Name: bendamustine
This medication has been identified as Treanda 45 mg/0.5 mL single-dose vial. It is supplied by Cephalon, Inc.
Treanda is used in the treatment of Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Treanda 45 mg/0.5 mL single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Treanda
- Generic Name
- bendamustine
- Strength
- 45 mg/0.5 mL single-dose vial
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cephalon, Inc.
- National Drug Code (NDC)
- 63459-0395 (Discontinued)
More about Treanda (bendamustine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
